Abstract: An editing system includes a first terminal and a second terminal. The first terminal is configured to transmit, to the second terminal, first associated information indicating a first position where a first content is to be displayed on a first display unit of the first terminal and a first size of the first content to be displayed on the first display unit. The second terminal is configured to receive the first associated information transmitted by the first terminal, display an associated image on a second display unit of the second terminal, and accept an editing operation while the associated image is being displayed. The editing operation includes at least one of a change operation being of changing at least one of a position or a size of the associated image or an input operation being of inputting a second content.

Abstract: A non-transitory computer-readable storage medium stores an editing program including a set of program instructions for an information processing apparatus comprising a controller and an input interface. The set of program instructions, when executed by the controller, causes the information processing apparatus to perform: acquiring a plurality of strokes inputted via the input interface; calculating a distance between two strokes of the acquired plurality of strokes; in response to determining that the calculated distance is shorter than a distance threshold, recognizing the two strokes as a same item; in response to determining that the calculated distance is longer than or equal to the distance threshold, recognizing the two strokes as separate items; and changing the distance threshold based on input via the input interface.

Abstract: The invention provides a latanoprost-containing aqueous pharmaceutical composition filled in a filter-equipped container, with the adsorption of latanoprost by the filter being prevented. In the latanoprost-containing aqueous pharmaceutical composition filled in the filter-equipped container, a nonionic surfactant is contained in the composition and the filter is made from at least one material selected from the group consisting of polyether sulfone, polyvinylidene fluoride, polycarbonate, and polytetrafluoroethylene.

Abstract: The purpose of the present invention is to create an immune tolerance-inducing agent used in therapy in which donor hematopoietic cells are transplanted into a recipient in order to induce immune tolerance in the recipient with respect to donor cells, tissue, or organs. By using an alpha-galactosylceramide-containing liposome in combination with a costimulatory-pathway-blocking substance, hematopoietic chimerism can be induced in the recipient by transplantation of donor hematopoietic cells, making it possible to induce immune tolerance in the recipient with respect to donor cells, tissue, or organs.

Abstract: The invention provides a latanoprost-containing aqueous pharmaceutical composition filled in a filter-equipped container, with the adsorption of latanoprost by the filter being prevented. In the latanoprost-containing aqueous pharmaceutical composition filled in the filter-equipped container, a nonionic surfactant is contained in the composition and the filter is made from at least one material selected from the group consisting of polyether sulfone, polyvinylidene fluoride, polycarbonate, and polytetrafluoroethylene.